Clinical Trial Update: Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating combination chemotherapy followed by stem cell transplant in high-risk neuroblastoma has completed enrollment/data collection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: University of Cologne | Conditions: Neuroblastoma | Phase 3 | Status: COMPLETED